BAX
Status-Quo-PlayerBaxter International
$17.63
+2.83%
as of 13 Apr
Power Core
Power Core in one sentence: Baxter's moat is the operational and clinical switching cost embedded in hospital workflows that are built around its specific IV solution formats, premixed drug concentrations, and infusion delivery systems.
Direction of Movement
Lateral Trajectory With Structural Tailwinds Emerging Slowly
ROC 200
-45.9%
Market data unavailable
Company Profile
Baxter International Inc. is a multinational healthcare company headquartered in Deerfield, Illinois, founded in 1931. It provides a broad portfolio of essential medical products and therapies focused on treating chronic and acute conditions in hospital and renal care settings. The company operates through key segments including Medical Products and Therapies, which encompass advanced surgery technologies to enhance surgical techniques, infusion therapies with sterile intravenous solutions, infusion systems and devices, and parenteral nutrition; Healthcare Systems and Technologies, offering smart bed systems, patient monitoring and diagnostic tools, respiratory health devices, and surgical equipment; and Pharmaceuticals, producing inhaled anesthetics and generic injectable pharmaceuticals for pain management, critical care, anti-infection, and oncology. These offerings support acute care, nutritional support, and surgical interventions worldwide, serving healthcare providers with innovative solutions for patient care across Americas, EMEA, and Asia-Pacific regions. Baxter International Inc. plays a vital role in advancing hospital-based care and connectivity solutions.